Norwegian startup Visoid has raised fresh funds for its AI software, which helps architects turn 3D models into striking ...
Mitochondria are the powerhouses in our cells, producing the energy for all vital processes. Using cryo-electron tomography, ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Regeneron has signed a collaboration deal potentially worth $1 billion with RNAi experts Alnylam Pharmaceuticals, to develop and commercialise drugs targeting eye, central nervous system (CNS ...
Regeneron and Sanofi’s PD-1 inhibitor Libtayo will be tested in tandem with a cancer vaccine developed by BioNTech in melanoma in people who have failed treatment with other checkpoint inhibitors.
It is a detailed view of the brain like never seen before.
Gadget Review on MSN1d
AI Tool Unveils Unprecedented 3D View of Brain Metabolism, Boosting Alzheimer's ResearchAI tool MetaVision3D creates detailed 3D maps of mouse brain metabolism, offering new insights into Alzheimer's and other ...
The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently established that Amgen’s biosimilar Pavblu violates key patents of Eylea. A U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback